B · Normal
[Zhongguancun: 36 products in production are included in the National Medical Insurance Catalog (2026)] On November 17, Zhongguancun (000931.SZ) announced that some of the drugs of Beijing Huasu, Shandong Huasu and Duoduo Pharmaceutical, the wholly-owned subsidiary of Sihuan Pharmaceutical, were included in the "National Basic Medical Insurance, Maternity Insurance and Work Injury Insurance Drug Catalog (2026)", and the company's total of 36 products in production were included in the catalog. Among them, products originally included in the 2025 catalog such as bisoprolol fumarate tablets and benidipine hydrochloride tablets will continue to be included. The newly included products include Beijing Huasu's "Oxycodone Hydrochloride Sustained-release Tablets", Shandong Huasu's "Bisoprolol Amlodipine Tablets", Duoduo Pharmaceutical's "Bromhexine Hydrochloride Injection" and "Febuxostat Tablets". The company reminds that the future sales of products included in the catalog may be affected by multiple factors such as changes in the market environment, and will not have a significant impact on the current operating performance. The catalog will be officially implemented on January 1, 2027.
A-share announcement express 🕐 2026-11-17 16:12

Related telegraphs

Comments

0/500
Captcha (click to refresh)
No comments yet